1.60 (-%)
As of Dec 06, 2024
Source:
Regulus Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing first-in-class drugs targeting microRNAs to treat diseases with significant unmet medical need.
Country | United States |
Headquarters | san diego, california |
Phone Number | ( 858 ) 202-6300 |
Industry | manufacturing |
CEO | Joseph P. Hagan |
Website | www.regulusrx.com |